Single + Multiple Ascending Dose and Food Effect Study of AZD7986 in Healthy Volunteers, PK, PD and Safety Study

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

December 3, 2014

Primary Completion Date

August 3, 2016

Study Completion Date

August 3, 2016

Conditions
Safety, Pharmacokinetics, Pharmacodynamics, Food Effect
Interventions
DRUG

AZD7986, oral solution, 1 to 50 mg/mL

Starting dose in single ascending dose part: 5 mg

DRUG

Placebo, oral solution

Matching placebo

Trial Locations (1)

HA1 3UJ

Research Site, Harrow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY